상세 보기
Bevacizumab-based triplet versus doublet chemotherapy as first-line treatment for metastatic right-sided colon cancer: Results of the KCSG CO19-18 phase II trial.
- Kim, Jee Hung;
- Kim, Hyunwook;
- Lee, Myung Ah;
- Hwang, In Gyu;
- Sym, Sun Jin;
- 외 8명
Citations
WEB OF SCIENCE
0- 제목
- Bevacizumab-based triplet versus doublet chemotherapy as first-line treatment for metastatic right-sided colon cancer: Results of the KCSG CO19-18 phase II trial.
- 저자
- Kim, Jee Hung; Kim, Hyunwook; Lee, Myung Ah; Hwang, In Gyu; Sym, Sun Jin; An, Ho Jung; Kim, Tae Won; Nam, Eun Mi; Kang, Seok Yun; Beom, Seung-Hoon; Kim, Han Sang; Shin, Sang Joon; Ahn, Joong Bae
- 발행일
- 2026-06
- 유형
- Meeting Abstract
- 권
- 44
- 호
- 16_SUPPL
- 언어
- ENG
- 출판사
- LIPPINCOTT WILLIAMS & WILKINS
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X